# Evaluate Safety, Tolerability, PK, Preliminary Clinical Activity of OB318 in Patients With Advanced Solid Malignancies

> clinical trial · VERIFIED · 2026-07-10

Status: TERMINATED · Sponsor: Oneness Biotech Co., Ltd. · Condition: Advanced Solid Malignancies

- Company: Oneness Biotech Co., Ltd.
- Sector: Advanced Solid Malignancies
- Primary source: https://clinicaltrials.gov/study/NCT02347228

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.